We are live on ! Find out more
PRQR icon

ProQR Therapeutics

64 hedge funds and large institutions have $286M invested in ProQR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

158% more capital invested

Capital invested by funds: $111M → $286M (+$175M)

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

39% more funds holding

Funds holding: 4664 (+18)

33.6% more ownership

Funds ownership: 52.68%86.28% (+34%)

21% more call options, than puts

Call options by funds: $2.48M | Put options by funds: $2.06M

Holders
64
Holders Change
+18
Holders Change %
+39.13%
% of All Funds
1.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
23
Reduced
10
Closed
6
Calls
$2.48M
Puts
$2.06M
Net Calls
+$425K
Net Calls Change
+$494K
Name Holding Trade Value Shares
Change
Change in
Stake
LCM
26
Laurion Capital Management
New York
$1.32M +$1.02M +200,000 New
Simplex Trading
27
Simplex Trading
Illinois
$807K +$609K +119,196 +3,990%
Two Sigma Investments
28
Two Sigma Investments
New York
$780K +$401K +78,484 +199%
FSA
29
Franklin Street Advisors
North Carolina
$661K +$204K +40,000 +67%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$617K
AA
31
ALPS Advisors
Colorado
$600K +$5.89K +1,152 +1%
UBS Group
32
UBS Group
Switzerland
$599K -$1.95M -381,488 -81%
Squarepoint
33
Squarepoint
New York
$497K +$283K +55,391 +280%
Tudor Investment Corp
34
Tudor Investment Corp
Connecticut
$496K +$383K +75,000 New
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$425K +$328K +64,258 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$361K +$10.2K +2,000 +4%
RJA
37
Raymond James & Associates
Florida
$264K +$204K +40,000 New
Millennium Management
38
Millennium Management
New York
$243K -$741K -145,046 -80%
AC
39
Apogem Capital
New York
$229K +$96.1K +18,799 +119%
Jane Street
40
Jane Street
New York
$219K +$98.9K +19,362 +140%
LCM
41
Landscape Capital Management
New Jersey
$215K +$166K +32,556 New
Citadel Advisors
42
Citadel Advisors
Florida
$188K +$145K +28,376 New
GCP
43
GSA Capital Partners
United Kingdom
$173K -$110K -21,473 -45%
SSA
44
Schonfeld Strategic Advisors
New York
$153K +$59.8K +11,700 +102%
Bank of America
45
Bank of America
North Carolina
$147K +$96.5K +18,895 +577%
Osaic Holdings
46
Osaic Holdings
Arizona
$141K +$109K +21,300 New
Geode Capital Management
47
Geode Capital Management
Massachusetts
$129K +$31.4K +6,148 +46%
Northern Trust
48
Northern Trust
Illinois
$118K +$91.5K +17,913 New
BC
49
Bridgefront Capital
Texas
$112K +$86.3K +16,883 New
TRCT
50
Tower Research Capital (TRC)
New York
$103K +$78.9K +15,446 +7,723%

PRQR Hedge Fund Activity: Q1 2021 in Review

64 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2021, worth a combined $286M — up 158% from $111M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRQR positions and 6 closed out — a net gain of 18 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $23.8M. The largest seller was Artal Group, exiting entirely with an estimated $5.02M sold.

  • 64 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2021, up from 46 in Q4 2020.
  • Funds reported $286M of ProQR Therapeutics stock for Q1 2021, up 158% quarter-over-quarter.
  • 24 funds opened new ProQR Therapeutics positions in Q1 2021 and 6 closed out, a net change of +18 holders.
  • The largest ProQR Therapeutics buyer in Q1 2021 was Fidelity Investments, an estimated $23.8M added.
  • The largest ProQR Therapeutics seller in Q1 2021 was Artal Group, an estimated $5.02M sold.

Based on aggregated 13F filings for Q1 2021.